DrugPatentWatch Database Preview
TENORMIN Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
When do Tenormin patents expire, and when can generic versions of Tenormin launch?
Tenormin is a drug marketed by Astrazeneca and Alvogen and is included in two NDAs.
The generic ingredient in TENORMIN is atenolol. There are thirty-four drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the atenolol profile page.
US ANDA Litigation and Generic Entry Outlook for Tenormin
A generic version of TENORMIN was launched as atenolol by ALVOGEN on December 13th, 2019.
Summary for TENORMIN
Recent Clinical Trials for TENORMIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| High Risk Obstetrical Consultants | Early Phase 1 |
| University of Tennessee Graduate School of Medicine | Early Phase 1 |
| BioHealthonomics Inc. | Phase 2 |
Pharmacology for TENORMIN
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
Synonyms for TENORMIN
| ( inverted question mark)-Atenolol |
| (?)-Atenolol |
| (+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide |
| (+-)-Atenolol |
| (+)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide |
| (+/-)-4-(2-Hydroxy-3-[(1-methylethyl)amino]propoxy)benzeneacetamide |
| (+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide |
| (+/-)-Atenolol |
| (1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide |
| (A+/-)-Atenolol |
| (r,s)-atenolol |
| (RS)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide |
| (RS)-Atenolol |
| (y)-Atenolol |
| 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol |
| 106020-65-9 |
| 122A687 |
| 2-(4-(2-hydroxy-3-(isopropylamino)propoxy) |
| 2-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide |
| 2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid |
| 2-(4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl)acetamide |
| 2-(4-{[(2S)-2-hydroxy-3-(propan-2-ylamino)propyl]oxy}phenyl)acetamide |
| 2-(4-{2-hydroxy-3-[(methylethyl)amino]propoxy}phenyl)acetamide |
| 2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide |
| 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide |
| 2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide |
| 2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide |
| 2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide |
| 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide |
| 2-{4-[2-Hydroxy-3-(isopropylamino)propoxy]-phenyl}acetamide |
| 2-{4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide |
| 2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide |
| 29122-68-7 |
| 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide |
| 4-[2 -Hydroxy-3 -(isopropylamino)-propoxy]phenylacetamide |
| 4-[2'-Hydroxy-3'-(isopropylamino)-propoxy]phenylacetamide |
| 4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide |
| 60966-51-0 |
| A 7655 |
| AB00052208_16 |
| AB00052208-13 |
| AB00052208-15 |
| AB0011597 |
| AC-8245 |
| AC1L1D99 |
| AC1Q1QBX |
| Acetamide, 2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)- |
| Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl) |
| Aircrit |
| AKOS005111050 |
| Alinor |
| Altol |
| AN-7253 |
| Anselol |
| Antipressan |
| ANW-45215 |
| API0001553 |
| Apo-Atenolol |
| ARONIS23884 |
| Artrenolol |
| Atcard |
| Atcardil |
| Atecard |
| Atehexal |
| Atenblock |
| Atendol |
| Atenet |
| Ateni |
| Atenil |
| Atenol |
| Atenol 1A pharma |
| Atenol acis |
| Atenol AL |
| Atenol Atid |
| Atenol Cophar |
| Atenol ct |
| Atenol Fecofar |
| Atenol Gador |
| Atenol Genericon |
| Atenol GNR |
| Atenol Heumann |
| Atenol MSD |
| Atenol NM Pharma |
| Atenol Nordic |
| Atenol PB |
| Atenol Quesada |
| Atenol Stada |
| Atenol Tika |
| Atenol Trom |
| Atenol von ct |
| Atenol-Mepha |
| Atenol-ratiopharm |
| Atenol-Wolff |
| Atenolin |
| atenolol |
| Atenolol (JAN/USP) |
| Atenolol (JP17/USP/INN) |
| Atenolol [USAN:BAN:INN:JAN] |
| Atenolol [USAN:INN:BAN:JAN] |
| Atenolol [USAN:USP:INN:BAN:JAN] |
| Atenolol 1.0 mg/ml in Acetonitrile |
| Atenolol Bp |
| Atenolol solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material |
| Atenolol, >=98% (TLC), powder |
| Atenolol, 98% |
| Atenolol, analytical reference material |
| Atenolol, European Pharmacopoeia (EP) Reference Standard |
| Atenolol, Pharmaceutical Secondary Standard; Certified Reference Material |
| Atenolol, United States Pharmacopeia (USP) Reference Standard |
| Atenolol,(S) |
| Atenololum |
| Atenololum [INN-Latin] |
| Atenomel |
| Atereal |
| Aterol |
| AX8005715 |
| BB_SC-01519 |
| BBC/163 |
| BBL009276 |
| BC201805 |
| BCP12899 |
| BDBM25753 |
| Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)- |
| BENZENEACETAMIDE, 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)-, (+-)- |
| Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- |
| benzeneacetamide, 4-[2'-hydroxy-3;-[(1-methylethyl)amino]propoxy]- |
| Betablok |
| Betacard |
| Betasyn |
| Betatop Ge |
| BG0049 |
| BIM-0050109.0001 |
| Blocotenol |
| Blokium |
| BRD-A20239487-001-02-5 |
| BRD-A20239487-001-15-7 |
| BRN 2739235 |
| BSPBio_002915 |
| CA0145 |
| Cardaxen |
| Cardiopress |
| CAS-29122-68-7 |
| CCG-39010 |
| CCRIS 4196 |
| CHEBI:2904 |
| CHEMBL24 |
| Corotenol |
| CPD000036768 |
| CS-2927 |
| CTK3J2163 |
| Cuxanorm |
| D00235 |
| DB00335 |
| DivK1c_000057 |
| dl-Atenolol |
| DSSTox_CID_2628 |
| DSSTox_GSID_22628 |
| DSSTox_RID_76663 |
| DTXSID2022628 |
| Duraatenolol |
| duratenol |
| EINECS 249-451-7 |
| EINECS 262-544-7 |
| EN300-119532 |
| EU-0100121 |
| Evitocor |
| Farnormin |
| Felo-Bits |
| FT-0622499 |
| FT-0693045 |
| GEO-03413 |
| GTPL548 |
| Hipres |
| HMS1569L13 |
| HMS1921H09 |
| HMS2090I19 |
| HMS2092D19 |
| HMS2233E06 |
| HMS3259K08 |
| HMS3260I04 |
| HMS3266K13 |
| HMS3369B14 |
| HMS3369D20 |
| HMS3369P20 |
| HMS500C19 |
| HSDB 6526 |
| HY-17498 |
| Hypoten |
| I01-3572 |
| Ibinolo |
| ICI 66,082 |
| ICI 66082 |
| ICI-66082 |
| IDI1_000057 |
| InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18) |
| Internolol |
| J10009 |
| Jenatenol |
| Juvental |
| KB-222053 |
| KB-47450 |
| KB-62479 |
| KBio1_000057 |
| KBio2_001844 |
| KBio2_004412 |
| KBio2_006980 |
| KBio3_002415 |
| KBioGR_000790 |
| KBioSS_001844 |
| KS-00000XIG |
| KS-000046IQ |
| KS-5341 |
| KSC492C6H |
| L000116 |
| Lo-ten |
| Lopac0_000121 |
| Loten |
| Lotenal |
| LP00121 |
| LS-28557 |
| LS-9707 |
| MCULE-9148694071 |
| METKIMKYRPQLGS-UHFFFAOYSA- |
| METKIMKYRPQLGS-UHFFFAOYSA-N |
| MFCD00057645 |
| MLS000069622 |
| MLS001066372 |
| MLS001074163 |
| MLS001304038 |
| MolPort-001-792-717 |
| MRF-0000571 |
| Myocord |
| NC00548 |
| NCGC00015007-06 |
| NCGC00015007-07 |
| NCGC00015007-08 |
| NCGC00015007-09 |
| NCGC00015007-10 |
| NCGC00015007-11 |
| NCGC00015007-13 |
| NCGC00024566-03 |
| NCGC00024566-04 |
| NCGC00024566-05 |
| NCGC00024566-06 |
| NCGC00024566-07 |
| NCGC00255122-01 |
| NCGC00260806-01 |
| Neatenol |
| NINDS_000057 |
| Normalol |
| Normiten |
| Noten |
| NSC-757832 |
| NSC757832 |
| Opera_ID_1283 |
| Oprea1_448775 |
| Oraday |
| Ormidol |
| Panapres |
| Pharmakon1600-01501127 |
| phenyl)acetamide |
| Plenacor |
| Premorine |
| Prenolol |
| Prenormine |
| Prinorm |
| Q-200656 |
| RTR-012731 |
| SAM002564193 |
| SBB056998 |
| SBI-0050109.P003 |
| SC-19545 |
| Scheinpharm Atenol |
| SCHEMBL4362 |
| Seles beta |
| Selobloc |
| Serten |
| Servitenol |
| SMR000036768 |
| SPBio_001482 |
| Spectrum_001364 |
| SPECTRUM1501127 |
| Spectrum2_001411 |
| Spectrum3_001448 |
| Spectrum4_000435 |
| Spectrum5_001509 |
| SR-01000000159 |
| SR-01000000159-2 |
| SR-01000000159-4 |
| SR-01000000159-5 |
| SR-01000000159-8 |
| ST024754 |
| ST2403914 |
| Stermin |
| STK528649 |
| Tenidon |
| Teno-basan |
| Tenobloc |
| Tenoblock |
| Tenolol |
| Tenoprin |
| Tenoretic (Salt/Mix) |
| Tenormin (TN) |
| Tenormine |
| Tenormine [French] |
| Tensimin |
| Tensotin |
| Tox21_302426 |
| Tox21_500121 |
| TR-012731 |
| Tredol |
| Unibloc |
| Uniloc |
| Vascoten |
| Vericordin |
| Wesipin |
| Xaten |
| Z-0828 |
| Z1541638518 |
| ZX-AS004380 |
US Patents and Regulatory Information for TENORMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | TENORMIN | atenolol | INJECTABLE;INJECTION | 019058-001 | Sep 13, 1989 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Alvogen | TENORMIN | atenolol | TABLET;ORAL | 018240-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Alvogen | TENORMIN | atenolol | TABLET;ORAL | 018240-004 | Apr 9, 1990 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Alvogen | TENORMIN | atenolol | TABLET;ORAL | 018240-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TENORMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alvogen | TENORMIN | atenolol | TABLET;ORAL | 018240-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Alvogen | TENORMIN | atenolol | TABLET;ORAL | 018240-004 | Apr 9, 1990 | Start Trial | Start Trial |
| Alvogen | TENORMIN | atenolol | TABLET;ORAL | 018240-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Alvogen | TENORMIN | atenolol | TABLET;ORAL | 018240-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Alvogen | TENORMIN | atenolol | TABLET;ORAL | 018240-001 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Alvogen | TENORMIN | atenolol | TABLET;ORAL | 018240-001 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
